Literature DB >> 32515024

The function and mechanism of circular RNAs in gastrointestinal tumours.

Hui Nie1, Yutong Wang1, Zhiming Liao1,2, Jianhua Zhou1, Chunlin Ou1.   

Abstract

Gastrointestinal tumours are tumours that originate in the digestive tract and have extremely high morbidity and mortality. The main categories include: oesophageal, gastric, and colorectal cancers. Circular RNAs are a new class of non-coding RNAs with a covalent closed-loop structure without a 5' cap or a 3' poly A tail, which can encode a small amount of polypeptide. Recent studies have shown that circRNAs are involved in multiple biological processes during the development of gastrointestinal tumours including proliferation, invasion and metastasis, radio- and chemoresistance, and inflammatory responses. Also, the clinical and pathological characteristics of the patient, such as staging and lymph node metastasis, are closely associated with the expression level of circRNAs. Further investigation of the function and the role of circRNAs in the development of gastrointestinal tumours will provide new directions for its clinical diagnosis and treatment.
© 2020 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  circular RNAs; gastrointestinal tumours; inflammatory responses; treatment

Year:  2020        PMID: 32515024     DOI: 10.1111/cpr.12815

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  19 in total

1.  Knockdown of circular RNA hsa_circ_0062270 suppresses the progression of melanoma via downregulation of CDC45.

Authors:  Tian Hao; Yi Yang; Juan He; Jia Bai; Yongjian Zheng; Zhanpeng Luo
Journal:  Histol Histopathol       Date:  2021-12-21       Impact factor: 2.303

2.  Microarray profiling identifies hsa_circ_0082003 as a novel tumor promoter for papillary thyroid carcinoma.

Authors:  J Ye; J-W Feng; W-X Wu; G-F Qi; F Wang; J Hu; L-Z Hong; S-Y Liu; Y Jiang
Journal:  J Endocrinol Invest       Date:  2022-09-17       Impact factor: 5.467

3.  The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer.

Authors:  Yutong Wang; Hui Nie; Huiling Li; Zhiming Liao; Xuejie Yang; Xiaoyun He; Jian Ma; Jianhua Zhou; Chunlin Ou
Journal:  Front Med (Lausanne)       Date:  2022-07-05

4.  Characteristics of Prognostic Programmed Cell Death-Related Long Noncoding RNAs Associated With Immune Infiltration and Therapeutic Responses to Colon Cancer.

Authors:  Yan Chen; Yue Zhang; Jiayi Lu; Zhongchen Liu; Shasha Zhao; Mengmei Zhang; Mingzhi Lu; Wen Xu; Fenyong Sun; Qi Wu; Qi Zhong; Zhongqi Cui
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

Review 5.  Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies.

Authors:  Xueping Tao; Yongfu Shao; Jianing Yan; Liyang Yang; Qihua Ye; Qingling Wang; Rongdan Lu; Junming Guo
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

6.  Overexpression of Long Noncoding RNA LBX2-AS1 Promotes the Proliferation of Colorectal Cancer.

Authors:  Qing Li; Hui Xie; Zefu Jin; Jing Huang; Shuting Wang; Zijian Zhang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 7.  The Emerging Landscape of Long Non-Coding RNAs in Colorectal Cancer Metastasis.

Authors:  Zhiming Liao; Hui Nie; Yutong Wang; Jingjing Luo; Jianhua Zhou; Chunlin Ou
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 8.  Emerging roles of exosomal miRNAs in diabetes mellitus.

Authors:  Xiaoyun He; Gaoyan Kuang; Yongrong Wu; Chunlin Ou
Journal:  Clin Transl Med       Date:  2021-06

Review 9.  The emerging role of super enhancer-derived noncoding RNAs in human cancer.

Authors:  Yutong Wang; Hui Nie; Xiaoyun He; Zhiming Liao; Yangying Zhou; Jianhua Zhou; Chunlin Ou
Journal:  Theranostics       Date:  2020-09-02       Impact factor: 11.556

Review 10.  Exosome microRNAs in Metabolic Syndrome as Tools for the Early Monitoring of Diabetes and Possible Therapeutic Options.

Authors:  Erika Cione; Roberto Cannataro; Luca Gallelli; Giovambattista De Sarro; Maria Cristina Caroleo
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.